Compound Detail
CHEMBL560774
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Basic Information
| ChEMBL ID | CHEMBL560774 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | LICZKOGIHNOERI-UHFFFAOYSA-N |
4
Targets
8
Activities
2
Assay Types
0
PK Parameters
13
Publications
0
Known Names
Molecular Properties
223.2
MW (Da)
2.80
ALogP
4
HBA
0
HBD
51.8
PSA (Ų)
0.67
QED
0
Ro5 Violations
2
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 7 meas. best 7.92
EC50 1 meas. best 6.73
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Caco-2 CHEMBL614058 | IC50 | 7.92 | 7.92 | 12.1 | 1 |
| HepG2 CHEMBL395 | IC50 | 7.26 | 7.26 | 55.4 | 1 |
| No relevant target CHEMBL2362975 | EC50 | 6.73 | 6.73 | 185.0 | 1 |
| WI-38 CHEMBL614391 | IC50 | 6.73 | 6.73 | 186.8 | 1 |
| No relevant target CHEMBL2362975 | IC50 | 5.71 | 5.71 | 1973.0 | 1 |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| Caco-2 | IC50 | = | 12.1 | nM | 7.92 | Anticancer activity against human Caco-2 cells assessed as reduction in cell via... | 33901898 |
| HepG2 | IC50 | = | 55.4 | nM | 7.26 | Anticancer activity against human HepG2 cells assessed as reduction in cell viab... | 33901898 |
| No relevant target | EC50 | = | 185.0 | nM | 6.73 | Metal chelating activity of the compound assessed as decrease in the Fe2+-phenan... | 33901898 |
| WI-38 | IC50 | = | 186.8 | nM | 6.73 | Cytotoxicity against human WI-38 cells assessed as reduction in cell viability a... | 33901898 |
| No relevant target | IC50 | = | 1973.0 | nM | 5.71 | Antioxidant activity assessed as DPPH radical scavenging activity after 30 mins ... | 33901898 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 33901898 | 10.1016/j.ejmech.2021.113475 | No relevant target | 2 |
| 33901898 | 10.1016/j.ejmech.2021.113475 | WI-38 | 2 |
| 19376704 | 10.1016/j.bmcl.2009.03.158 | DU-145 | 1 |
| 19376704 | 10.1016/j.bmcl.2009.03.158 | LNCaP | 1 |
| 19376704 | 10.1016/j.bmcl.2009.03.158 | MCF7 | 1 |
| 19376704 | 10.1016/j.bmcl.2009.03.158 | NON-PROTEIN TARGET | 1 |
| 19376704 | 10.1016/j.bmcl.2009.03.158 | HCT-116 | 1 |
| 19376704 | 10.1016/j.bmcl.2009.03.158 | MIA PaCa-2 | 1 |
| 19376704 | 10.1016/j.bmcl.2009.03.158 | PC-3 | 1 |
| 33901898 | 10.1016/j.ejmech.2021.113475 | HepG2 | 1 |
| 33901898 | 10.1016/j.ejmech.2021.113475 | Caco-2 | 1 |
| 33901898 | 10.1016/j.ejmech.2021.113475 | ADMET | 1 |
| 33901898 | 10.1016/j.ejmech.2021.113475 | Unchecked | 1 |
Data from ChEMBL 36 via Core Engine